Both in Medical Labs
Advanced Biomed vs Sera Prognostics
Over the past year ADVB returned −77.5% and SERA returned −37.8%; their daily moves had a correlation of -0.04.
ADVB −77.5% SERA −37.8%Growth of $1, one year, split-adjusted
| Metric | ADVB | SERA |
|---|---|---|
| Price | $2.08 | $1.99 |
| Market cap | $3.4M | $78.5M |
| Today | −9.78% | −2.45% |
| 1 month | −69.2% | −4.8% |
| 6 months | −65.2% | +4.7% |
| Year to date | −64.4% | −32.5% |
| 1 year | −81.7% | −40.6% |
| Revenue growth (YoY) | — | +76.5% |
| Gross margin | 100.0% | −66.7% |
| Net margin | 544.5% | −30463.3% |
| P/E (TTM) | 0.5× | — |
| Price / sales | 26.9× | 1,121.5× |
| Net cash | $385.5K | $46.4M |
| Dividend yield | — | — |
| Volatility (60d) | 115.6% | 33.0% |
| Short % of float | 1.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).